M&A

Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M
Xconomy
Mon, 07/23/18 - 10:24 pm
Sangamo BioSciences
M&A
TxCell
autoimmune disease
cell therapy
Astellas exploring selling Europe assets for $500m
GoinPharma
Fri, 07/20/18 - 09:41 am
Astellas
Europe
M&A
Nabbing late-stage drug, PTC acquires gene therapy startup Agilis for $200M in cash/stock
Endpoints
Thu, 07/19/18 - 11:23 pm
PTC Therapeutics
gene therapy
M&A
Agilis
Gilead’s Kite bags option to buy gamma delta startup Gadeta
Fierce Biotech
Thu, 07/19/18 - 11:17 am
Gilead Sciences
Kite Pharma
Gadeta
T-cell receptors
M&A
Publicis Health acquires Payer Sciences
Medical Marketing and Media
Tue, 07/17/18 - 03:50 pm
Publicis Health
M&A
Payer Sciences
payers
Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
Fierce Pharma
Mon, 07/16/18 - 10:34 pm
Amgen
biosimilars
Neulasta
Alexion
M&A
CVS-Aetna merger may get the green light
Axios
Fri, 07/13/18 - 11:13 pm
CVS Health
Aetna
insurers
M&A
AngioDynamics CEO Clemmer is on the M&A trail
Mass Device
Fri, 07/13/18 - 11:07 pm
AngioDynamics
Pharma CEOs
Jim Clemmer
M&A
devices
BioCryst nixes merger, sending Idera stock down
Biopharma Dive
Thu, 07/12/18 - 06:19 pm
Idera
Biocryst
M&A
Gerresheimer to acquire Sensile Medical and its drug-delivery tech
Mass Device
Thu, 07/12/18 - 11:34 am
devices
Gerresheimer
Sensile Medical
M&A
4 Things You Need to Know About Pfizer's Restructuring Plans
Motley Fool
Wed, 07/11/18 - 11:29 pm
Pfizer
restructuring
M&A
consumer health
reorganization
Otsuka Ramps Up Its Antibody Game with $430M Visterra Acquisition
Xconomy
Wed, 07/11/18 - 03:12 pm
Otsuka
Visterra
M&A
Otsuka Finds Paradise in Renal Denervation Market
Medical Devices and Diagnostics Industry
Tue, 07/10/18 - 11:01 pm
Otsuka
ReCor Medical
renal denervation
devices
M&A
FTC Clears Takeda's Acquisition of Shire
CP Wire
Tue, 07/10/18 - 11:46 am
FTC
M&A
Takeda
Shire
Five-year low for medical device mergers
EP Vantage
Tue, 07/10/18 - 11:42 am
devices
M&A
FTC Clears Takeda's Acquisition of Shire
Tue, 07/10/18 - 09:49 am
Takeda Pharmaceuticals
Shire Pharmaceuticals
M&A
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
M&A
biotech
Celgene
Sanofi
Impact Biomedicines
Bioverativ
GSK
Takeda
Shire
JNJ
Boston Scientific Continues to Be Relentless with M&A
Medical Devices and Diagnostics Industry
Thu, 07/5/18 - 10:58 am
Boston Scientific
devices
Cryterion Medical
M&A
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Thu, 07/5/18 - 10:50 am
Takeda
Shire
M&A
Japan
Fireworks among the small and mid-cap device makers
EP Vantage
Thu, 07/5/18 - 10:07 am
devices
valuation
innovation
M&A

Pages